BERTopic results plotkins vaccines

Topic 0
  Auto Label:        Antibodies
  Descriptive Label: Antibodies
  Keywords:          pertussis, bordetella, bordetella pertussis, pertussis vaccine, acellular, pertussis vaccines, toxin, pertussis toxin, warfel jm, warfel
  Summary:           Pertussis vaccines, whether whole cell or acellular, contain multiple components of the bacteria. Toxins and adherence factors are important in pathogenesis, and studies show that whereas antibodies against any of these reduces risk, antibod- ies against multiple virulence factors reduce risk even more.

Topic 1
  Auto Label:        Malaria
  Descriptive Label: Malaria
  Keywords:          rts, malaria, plasmodium, circumsporozoite, cell immunity, circumsporozoite protein, malaria vaccine, appear, t, protein
  Summary:           It has usually been assumed that T-cell responses are the important protective correlate for bacille Calmette-Guérin (BCG) vaccine and tuberculosis in general. It has been difficult to prove that assumption.

Topic 2
  Auto Label:        Metrics
  Descriptive Label: Metrics
  Keywords:          surrogate, surrogate endpoints, endpoints, treatment, clinical trials, validation, meta, endpoints clinical, fleming tr, fleming
  Summary:           Surrogate endpoints in clinical trials: definition and operational criteria. Estimating the proportion of treatment effect explained by a surrogate marker.

Topic 3
  Auto Label:        Hiv
  Descriptive Label: Hiv
  Keywords:          hiv-1, v2, vaccine efficacy, haynes, efficacy trial, trial, bf, haynes bf, envelope, edlefsen
  Summary:           A striking example of the importance of antibody function has been reported after an HIV vaccine trial in Thailand. IgG3 antibodies directed against the V1-V2 loops of virus were shown to cor- relate with protection.

Topic 4
  Auto Label:        Vaccines
  Descriptive Label: Vaccines
  Keywords:          systems, yellow fever, yellow, fever, fever vaccine, systems vaccinology, vaccinology, immunology, biology, systems biology
  Summary:           This book describes the immunology sur- Principle 2: The Mechanism of Protection by Vaccination Is Not Necessarily the Same Mechanism as Recovery From Infection. Principle 3: A Large Challenge Dose Can Overcome Immunity Principle 4: Most Current Vaccines Protect Through Antibodies Principle 6: Antibody Must Be Functional

Topic 5
  Auto Label:        Immune
  Descriptive Label: Immune
  Keywords:          induced vaccination, protection vaccination, correlates protection, vaccination, protection induced, induced, correlates, major infectious, 2010;17(7):1055, infectious diseases
  Summary:           Plotkin SA. Correlates of protection induced by vaccination.

Topic 6
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Varicella
  Keywords:          zoster, herpes zoster, herpes, zoster vaccine, zoster virus, dorsal, specific immune, varicella, varicella virus, virus specific
  Summary:           The current vaccine consists of live varicella virus in large quantity or the gE protein of the virus. In both cases the vaccines elicit both antibodies and cellular responses.

Topic 7
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immune
  Keywords:          baseline, individual, placebo, immune response, endpoint, surrogate endpoint, technique, baseline variables, application vaccine, receive
  Summary:           VE curve statistical methods incorporate techniques for ‘filling in’ the counterfactual immune responses of placebo recipients. The “baseline immune response predic- tor’ technique develops a model from vaccine recipients predicting individual immune response biomarkers.

Topic 8
  Auto Label:        Influenza
  Descriptive Label: Influenza – Vaccines
  Keywords:          influenza vaccines, influenza, attenuated inactivated, induced live, inactivated influenza, attenuated, vaccines, immune correlates, live attenuated, systems
  Summary:           Live attenuated and inactivated influenza vaccines in children. J Infect Dis.

Topic 9
  Auto Label:        Preimmunization
  Descriptive Label: Preimmunization
  Keywords:          cop, developing cops, simple, cops, determination, issues, statistical issues, possible, developing, efficacy trials
  Summary:           A CoP is an immune efficacy trial participants, to make possible measurement of preimmunization predictors of the candidate CoP in most disease cases. Unavailability of baseline samples has been one of the greatest limiting factors for CoP assessment in efficacy trials.

Topic 10
  Auto Label:        Rotavirus
  Descriptive Label: Rotavirus
  Keywords:          rotavirus, human rotavirus, monovalent inactivated, inactivated human, animal studies, protection rota-, immunity evidence, studies hum, a61 correlates, evidence animal
  Summary:           Do a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.

Topic 11
  Auto Label:        Influenza
  Descriptive Label: Influenza – Antibody
  Keywords:          levels, rate, high levels, influenza, high, block virus, influenza vaccine, cytotoxic t, occurred, households
  Summary:           Fig. 3.1 shows a retrospective analysis of the relationship between antibody responses to influenza hemagglutinin and protec- tion against disease.

Topic 12
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immunodeficiency
  Keywords:          siv, effector, rhesus, vector, early, pathogenic, effector memory, line, proteins, highly pathogenic
  Summary:           An interesting discovery was made recently in simian immunodeficiency virus (SIV)–infected rhesus monkeys. The vector induced effector CD8+ T cells directed against the SIV proteins and was able to abort early SIV infections.

Topic 13
  Auto Label:        Pneumococcal
  Descriptive Label: Pneumococcal
  Keywords:          conjugate vaccine, conjugate, pneumococcal, pneumococcal conjugate, meningococcal, infants, valent, old, elisa, produced
  Summary:           A study of meningococcal Group C polysaccharide vaccine conducted in Quebec showed the difference in function between antibodies measured by ELISA or by bacterial killing. Adults produced both types of antibodies and were highly protected.

Topic 14
  Auto Label:        Cohort
  Descriptive Label: Cohort
  Keywords:          cohort, case cohort, case, epidemiology, lifetime, samuelsen stratified, identifiability exchangeability, variance estimation, stratified case, results case
  Summary:           Breslow NE, Lumley T, Ballantyne CM, et al. Using the whole cohort in the analysis of case-cohort data.

Topic 15
  Auto Label:        Statistical
  Descriptive Label: Statistical
  Keywords:          article25, statistics biological, biological, 4th, library, laboratory, tection 1997;89:283, hubbard, correlates pro-, 1997;89:283
  Summary:           Sokal RR, Rohlf FJ. Biometry: The Principles and Practice of Statistics In Biological Research.

Topic 16
  Auto Label:        Biometrics
  Descriptive Label: Biometrics – Stratification
  Keywords:          causal, principal stratification, stratification, principal, stratification causal, surrogate, biometrics, approach, approach improved, improved estima-
  Summary:           Principal stratification in causal infer- ence. Biometrics.

Topic 17
  Auto Label:        Ebola
  Descriptive Label: Ebola
  Keywords:          promises, results year, obstacles clemens, vaccine promises, clemens trial, vaccines implications, toxic, race, particularly antibody, protection particularly
  Summary:           Recent illustration of probable cocorrelates is the chim- panzee adenovirus vectored vaccine against Ebola virus. Whereas monkeys that generate ELISA titers of 2000 or more almost always survive an Ebola challenge, passive antibody did not protect.

Topic 18
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Vaccinees
  Keywords:          anamnestic, anti-, response, vaccinees, approaches assessing, s19 per-, later life, usually protected, exposed virus.59–62, life vaccinees
  Summary:           Hepatitis B vaccine is highly immunogenic at birth, but anti- bodies are frequently lost later in life. Nevertheless, vaccinees are usually protected because they have an anamnestic anti- body response when exposed to the virus.

Topic 19
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immune – T19
  Keywords:          ve, cop, pathogen, immune response, biomarker, subgroups, useful cop, % vaccinees, end, cops
  Summary:           The determination of a correlate of protection (CoP) by a vaccine is often critical to its development. A CoP permits measurement of consistent lot potency of a vaccine and differentiation of susceptible from immune individuals.

Topic 20
  Auto Label:        Cytomegalovirus
  Descriptive Label: Cytomegalovirus
  Keywords:          pfu, cytomegalovirus, naturally seropositive, seronegative, naturally, low passage, seropositive, subjects, passage, infected
  Summary:           Seronegative, naturally seropositive, and previously vaccinated subjects were challenged parenterally with 10, 100, or 1000 PFU of a low-passage natural strain of cytomegalovirus. The vaccine prevented infection by 100PFU of the challenge virus, but not by 1000PFU.

Topic 21
  Auto Label:        Influenza
  Descriptive Label: Influenza – Antibody – T21
  Keywords:          nasal, live attenuated, hae- mophilus, virus infections, thoughts vaccine, infections thoughts, ainai, dren vaccinated, attenuated ainai, vaccinated live
  Summary:           A good example of cocorrelates may be derived from studies of influenza. The live, attenuated intranasal vaccine generates both serum antibody and nasal IgA mucosal antibody.

Topic 22
  Auto Label:        Cd4
  Descriptive Label: Cd4
  Keywords:          subsets, clearly, t cell, cell subsets, responses correlates, functions, t, cell, clearly learned, protective functions
  Summary:           There is clearly much still to be learned about T-cell responses as correlates. CD4+ T cells exist in many varieties with different helper functions for B and T cells that influence protection directly or indirectly.

Topic 23
  Auto Label:        Rubella
  Descriptive Label: Rubella
  Keywords:          neutralization, strains, rubella vaccines, glutination, hemag-, rubella, hemag- glutination, inhibition, neut neutralization, realized important
  Summary:           neutralization of viruses and killing of bacteria are often mCoP. It has been increasingly realized that there are other important antibody functions.

Topic 24
  Auto Label:        Estimation
  Descriptive Label: Estimation
  Keywords:          likelihood, weighted, sampling, stage, estimation, estimation semipara-, reilly m., m. optimal, transformation models, sampling strategies
  Summary:           Breslow NE, Lumley T, Ballantyne CM, et al. Improved Horvitz- Thompson estimation of model parameters from two-phase stratified samples.

Topic 25
  Auto Label:        Biometrics
  Descriptive Label: Biometrics – Gate
  Keywords:          endpoints, principal, principal biometrics, endpoints springer, comparing, comparing biomarkers, tsiatis, evaluation endpoints, biometrics comparing, springer evaluating
  Summary:           The Evaluation of Surro- gate Endpoints. In: Gail MH, Kricke- berg K, Samet J, Tsiatis

Topic 26
  Auto Label:        Expertconsult
  Descriptive Label: Expertconsult
  Keywords:          statistical learning, learning, introduction statistical, references, learning applications, introduction, applications, r, springer, eds introduction
  Summary:           An Introduction to Statistical Learning: with Applications, in R, is published by Springer. References for this chapter are available at ExpertConsult.

Topic 27
  Auto Label:        Immunity
  Descriptive Label: Immunity
  Keywords:          poxvirus, poxvirus infection, secondary, reader, t, cells, t cells, cd8, +, reader mind
  Summary:           This chapter seeks to simplify immunology in order to identify principles of protection. Serum and mucosal antibodies come in different isotypes and functionality.

Topic 28
  Auto Label:        Memory
  Descriptive Label: Memory
  Keywords:          principle, relation, principle memory, protect cocorrelates, factor protect, principle factor, phenomena principle, specific phenomena, relation specific, defined relation
  Summary:           Protection Must Be Defined in Relation to Specific Phenomena Principle 8:

Topic 29
  Auto Label:        Chlamydia
  Descriptive Label: Chlamydia
  Keywords:          chlamydia, trachomatis, chlamydia trachomatis, protective immunity, tularemia, macaques foster, sufficient ifn, trachomatis cell, immunity chlamydia, produce sufficient
  Summary:           CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.

Topic 30
  Auto Label:        Influenza
  Descriptive Label: Influenza – Pulmonary
  Keywords:          doherty, absence cells, cells, influenza, absence, cells correlate, type virus, disease protection, correlate disease, clearing
  Summary:           CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Preexisting influenza- specific CD4+.

Topic 31
  Auto Label:        Influenza
  Descriptive Label: Influenza – Granzyme
  Keywords:          older adults, older, adults, response vacci-, adults vaccine, nation older, vacci- nation, vaccine thijs, trial jama, thijs efficacy
  Summary:           Granzyme B: Correlates with protection and enhanced CTL response to influenza in older adults.

Topic 32
  Auto Label:        Bioanalytical
  Descriptive Label: Bioanalytical
  Keywords:          center, evaluation research, guidance, center drug, industry, services, cder center, drug, cder, guidance industry
  Summary:           European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Guideline on Bioanalytical Method Vali- dation. FDA Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics.

Topic 33
  Auto Label:        Alphavirus
  Descriptive Label: Alphavirus
  Keywords:          measles, level, cell deficient, deficient humans, deficient, monkeys, b, humans, level antibody, protection measles
  Summary:           The level of antibodies that protect against measles has been defined. A level of 120 mIU of antibody measured by ELISA indicates protection against clinical measles and infection.

Topic 34
  Auto Label:        Tuberculosis
  Descriptive Label: Tuberculosis
  Keywords:          tuberculosis, mcaleer, lishment, il-17, estab-, defense immunol, immune defense, directing, traffic, il-17 estab-
  Summary:           IL-23 and IL-17 in the estab- lishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium

Topic 35
  Auto Label:        35
  Descriptive Label: 35
  Keywords:          res 1996;91(433):14, ageing res, 1996;91(433):14, res, ageing, , , , , 
  Summary:           35 Ageing

Topic 36
  Auto Label:        Protec
  Descriptive Label: Protec
  Keywords:          protec- tion, protec-, correlates protec-, tion, dunning, model immunological, acute, ellner, jj, tion med
  Summary:           Jokinen JT, Ahman H, Kilpi TM, et al. Concentration of anti- pneumococcal antibodies as a serological correlate of protec-

Topic 37
  Auto Label:        Clin
  Descriptive Label: Clin
  Keywords:          med, , , , , , , , , 
  Summary:           Clin Infect Dis

Topic 38
  Auto Label:        Correlates
  Descriptive Label: Correlates
  Keywords:          correlates complexity, nonmechanistic correlates, convenient nonmechanistic, principle convenient, relative principle, correlates relative, principle correlates, complexity, convenient, complexity correlates
  Summary:           Principle 5: Correlates

Topic 39
  Auto Label:        Osdesign
  Descriptive Label: Osdesign
  Keywords:          control studies, optimal, error, studies, control, design, designing optimal, evaluation design, stage epidemiologi-, epidemiologi- cal
  Summary:           R is an R package for the analysis, evaluation, and design of two-phase and case-control studies.

Topic 40
  Auto Label:        Antibody
  Descriptive Label: Antibody
  Keywords:          antibodies, bacteremia, rabies, attachment, administration, levels times, pre-, times, agents, fact
  Summary:           Protection against infection may relate to different immune markers than protection against disease. Polio is an example in which paralysis can be prevented by serum antibodies.

Topic 41
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Immunological
  Keywords:          varicella med, evaluating antibody, models evaluating, statistical models, use statistical, trials use, protection vaccine, protection varicella, assessing immunological, framework assessing
  Summary:           A framework for assessing immunological correlates of protection in vaccine trials. Qin L, Gilbert PB, Corey L, et al.

Topic 42
  Auto Label:        Estimates
  Descriptive Label: Estimates
  Keywords:          area, efficacy trials, assays, area statistical, cops, dimensional, biomarkers, trials, b, low
  Summary:           Statistical power for detecting a CoP is eroded for biomarkers with low signal-to-noise ratios. Table 3.4 gives our best estimates of CoPs for currently licensed vaccines.

Topic 43
  Auto Label:        Serum
  Descriptive Label: Serum
  Keywords:          plexed, mcop provides, brown, dugast, multi-, ncop.70–72, agreed, throughput, samples immunol, cal samples
  Summary:           High-throughput, multi- plexed IgG subclassing of antigen-specific


Document-Level Assignments:
Doc 1: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 2: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 0.70687913
Doc 3: Topic 19 (Auto: Vaccine; Descriptive: Vaccine – Immune – T19), Prob: 0.62571929
Doc 4: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 5: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 6: Topic 19 (Auto: Vaccine; Descriptive: Vaccine – Immune – T19), Prob: 1.00000000
Doc 7: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 0.67746204
Doc 8: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 9: Topic 27 (Auto: Immunity; Descriptive: Immunity), Prob: 0.60295896
Doc 10: Topic 28 (Auto: Memory; Descriptive: Memory), Prob: 0.69828721
Doc 11: Topic 28 (Auto: Memory; Descriptive: Memory), Prob: 1.00000000
Doc 12: Topic 40 (Auto: Antibody; Descriptive: Antibody), Prob: 1.00000000
Doc 13: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 14: Topic 33 (Auto: Alphavirus; Descriptive: Alphavirus), Prob: 1.00000000
Doc 15: Topic 27 (Auto: Immunity; Descriptive: Immunity), Prob: 1.00000000
Doc 16: Topic 35 (Auto: 35; Descriptive: 35), Prob: 1.00000000
Doc 17: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 18: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 19: Topic 20 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.55659249
Doc 20: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 21: Topic 40 (Auto: Antibody; Descriptive: Antibody), Prob: 1.00000000
Doc 22: Topic 38 (Auto: Correlates; Descriptive: Correlates), Prob: 1.00000000
Doc 23: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.91310467
Doc 24: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 1.00000000
Doc 25: Topic 23 (Auto: Rubella; Descriptive: Rubella), Prob: 1.00000000
Doc 26: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.91051821
Doc 27: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 28: Topic 23 (Auto: Rubella; Descriptive: Rubella), Prob: 1.00000000
Doc 29: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 1.00000000
Doc 30: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.24700809
Doc 31: Topic 22 (Auto: Cd4; Descriptive: Cd4), Prob: 0.49125663
Doc 32: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 0.40490204
Doc 33: Topic 29 (Auto: Chlamydia; Descriptive: Chlamydia), Prob: 0.83276206
Doc 34: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 35: Topic 22 (Auto: Cd4; Descriptive: Cd4), Prob: 1.00000000
Doc 36: Topic 28 (Auto: Memory; Descriptive: Memory), Prob: 0.84476482
Doc 37: Topic 21 (Auto: Influenza; Descriptive: Influenza – Antibody – T21), Prob: 1.00000000
Doc 38: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.33519182
Doc 39: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 40: Topic 17 (Auto: Ebola; Descriptive: Ebola), Prob: 1.00000000
Doc 41: Topic 28 (Auto: Memory; Descriptive: Memory), Prob: 1.00000000
Doc 42: Topic 18 (Auto: Vaccine; Descriptive: Vaccine – Vaccinees), Prob: 1.00000000
Doc 43: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 0.79065023
Doc 44: Topic 38 (Auto: Correlates; Descriptive: Correlates), Prob: 1.00000000
Doc 45: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 0.74067536
Doc 46: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 47: Topic 43 (Auto: Serum; Descriptive: Serum), Prob: 1.00000000
Doc 48: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 49: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 50: Topic 42 (Auto: Estimates; Descriptive: Estimates), Prob: 1.00000000
Doc 51: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 52: Topic 19 (Auto: Vaccine; Descriptive: Vaccine – Immune – T19), Prob: 1.00000000
Doc 53: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 54: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 0.46436603
Doc 55: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 56: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 57: Topic 19 (Auto: Vaccine; Descriptive: Vaccine – Immune – T19), Prob: 1.00000000
Doc 58: Topic 19 (Auto: Vaccine; Descriptive: Vaccine – Immune – T19), Prob: 0.94985029
Doc 59: Topic 38 (Auto: Correlates; Descriptive: Correlates), Prob: 1.00000000
Doc 60: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 1.00000000
Doc 61: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 0.82242242
Doc 62: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 63: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 0.62250760
Doc 64: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 65: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 0.45726229
Doc 66: Topic 9 (Auto: Preimmunization; Descriptive: Preimmunization), Prob: 0.96685832
Doc 67: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 68: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 69: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 70: Topic 42 (Auto: Estimates; Descriptive: Estimates), Prob: 1.00000000
Doc 71: Topic 26 (Auto: Expertconsult; Descriptive: Expertconsult), Prob: 1.00000000
Doc 72: Topic 26 (Auto: Expertconsult; Descriptive: Expertconsult), Prob: 0.56633169
Doc 73: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 0.56376195
Doc 74: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 0.80918259
Doc 75: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 1.00000000
Doc 76: Topic 37 (Auto: Clin; Descriptive: Clin), Prob: 1.00000000
Doc 77: Topic 41 (Auto: Vaccine; Descriptive: Vaccine – Immunological), Prob: 1.00000000
Doc 78: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 1.00000000
Doc 79: Topic 37 (Auto: Clin; Descriptive: Clin), Prob: 1.00000000
Doc 80: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 0.71917438
Doc 81: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 0.59405157
Doc 82: Topic 36 (Auto: Protec; Descriptive: Protec), Prob: 1.00000000
Doc 83: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 84: Topic 33 (Auto: Alphavirus; Descriptive: Alphavirus), Prob: 1.00000000
Doc 85: Topic 27 (Auto: Immunity; Descriptive: Immunity), Prob: 1.00000000
Doc 86: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 87: Topic 27 (Auto: Immunity; Descriptive: Immunity), Prob: 1.00000000
Doc 88: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 89: Topic 20 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 90: Topic 5 (Auto: Immune; Descriptive: Immune), Prob: 1.00000000
Doc 91: Topic 18 (Auto: Vaccine; Descriptive: Vaccine – Vaccinees), Prob: 1.00000000
Doc 92: Topic 21 (Auto: Influenza; Descriptive: Influenza – Antibody – T21), Prob: 0.87969856
Doc 93: Topic 11 (Auto: Influenza; Descriptive: Influenza – Antibody), Prob: 1.00000000
Doc 94: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 95: Topic 23 (Auto: Rubella; Descriptive: Rubella), Prob: 0.93583829
Doc 96: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 0.92428814
Doc 97: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.36598061
Doc 98: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 99: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.50863885
Doc 100: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.34854740
Doc 101: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 102: Topic 36 (Auto: Protec; Descriptive: Protec), Prob: 1.00000000
Doc 103: Topic 34 (Auto: Tuberculosis; Descriptive: Tuberculosis), Prob: 1.00000000
Doc 104: Topic 34 (Auto: Tuberculosis; Descriptive: Tuberculosis), Prob: 1.00000000
Doc 105: Topic 37 (Auto: Clin; Descriptive: Clin), Prob: 1.00000000
Doc 106: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 107: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 108: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 109: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 110: Topic 29 (Auto: Chlamydia; Descriptive: Chlamydia), Prob: 0.79308084
Doc 111: Topic 23 (Auto: Rubella; Descriptive: Rubella), Prob: 0.71935486
Doc 112: Topic 29 (Auto: Chlamydia; Descriptive: Chlamydia), Prob: 1.00000000
Doc 113: Topic 29 (Auto: Chlamydia; Descriptive: Chlamydia), Prob: 1.00000000
Doc 114: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 1.00000000
Doc 115: Topic 21 (Auto: Influenza; Descriptive: Influenza – Antibody – T21), Prob: 1.00000000
Doc 116: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 0.93124842
Doc 117: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 0.78242132
Doc 118: Topic 30 (Auto: Influenza; Descriptive: Influenza – Pulmonary), Prob: 1.00000000
Doc 119: Topic 30 (Auto: Influenza; Descriptive: Influenza – Pulmonary), Prob: 1.00000000
Doc 120: Topic 30 (Auto: Influenza; Descriptive: Influenza – Pulmonary), Prob: 0.90024586
Doc 121: Topic 31 (Auto: Influenza; Descriptive: Influenza – Granzyme), Prob: 1.00000000
Doc 122: Topic 35 (Auto: 35; Descriptive: 35), Prob: 1.00000000
Doc 123: Topic 31 (Auto: Influenza; Descriptive: Influenza – Granzyme), Prob: 1.00000000
Doc 124: Topic 30 (Auto: Influenza; Descriptive: Influenza – Pulmonary), Prob: 0.84704514
Doc 125: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 126: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 127: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 128: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 129: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 130: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 131: Topic 17 (Auto: Ebola; Descriptive: Ebola), Prob: 1.00000000
Doc 132: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 0.68475051
Doc 133: Topic 17 (Auto: Ebola; Descriptive: Ebola), Prob: 0.65287239
Doc 134: Topic 17 (Auto: Ebola; Descriptive: Ebola), Prob: 0.70960166
Doc 135: Topic 33 (Auto: Alphavirus; Descriptive: Alphavirus), Prob: 1.00000000
Doc 136: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 137: Topic 18 (Auto: Vaccine; Descriptive: Vaccine – Vaccinees), Prob: 1.00000000
Doc 138: Topic 18 (Auto: Vaccine; Descriptive: Vaccine – Vaccinees), Prob: 0.96026090
Doc 139: Topic 18 (Auto: Vaccine; Descriptive: Vaccine – Vaccinees), Prob: 0.89479127
Doc 140: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 141: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 1.00000000
Doc 142: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 1.00000000
Doc 143: Topic 20 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.28449927
Doc 144: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 145: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 146: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Immunodeficiency), Prob: 0.61928806
Doc 147: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 148: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 149: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.15051036
Doc 150: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 151: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.28750673
Doc 152: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.50863885
Doc 153: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 154: Topic 15 (Auto: Statistical; Descriptive: Statistical), Prob: 1.00000000
Doc 155: Topic 32 (Auto: Bioanalytical; Descriptive: Bioanalytical), Prob: 1.00000000
Doc 156: Topic 32 (Auto: Bioanalytical; Descriptive: Bioanalytical), Prob: 1.00000000
Doc 157: Topic 15 (Auto: Statistical; Descriptive: Statistical), Prob: 0.92176890
Doc 158: Topic 15 (Auto: Statistical; Descriptive: Statistical), Prob: 1.00000000
Doc 159: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 160: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 1.00000000
Doc 161: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 162: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 163: Topic 43 (Auto: Serum; Descriptive: Serum), Prob: 1.00000000
Doc 164: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 165: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 0.99881608
Doc 166: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 167: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 1.00000000
Doc 168: Topic 15 (Auto: Statistical; Descriptive: Statistical), Prob: 0.91858154
Doc 169: Topic 26 (Auto: Expertconsult; Descriptive: Expertconsult), Prob: 1.00000000
Doc 170: Topic 22 (Auto: Cd4; Descriptive: Cd4), Prob: 1.00000000
Doc 171: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 1.00000000
Doc 172: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 1.00000000
Doc 173: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 0.93814580
Doc 174: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.49553070
Doc 175: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.49553070
Doc 176: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.37984546
Doc 177: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.48546055
Doc 178: Topic 16 (Auto: Biometrics; Descriptive: Biometrics – Stratification), Prob: 1.00000000
Doc 179: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.48546055
Doc 180: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.64851413
Doc 181: Topic 16 (Auto: Biometrics; Descriptive: Biometrics – Stratification), Prob: 0.75258965
Doc 182: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.43694826
Doc 183: Topic 25 (Auto: Biometrics; Descriptive: Biometrics – Gate), Prob: 0.82178219
Doc 184: Topic 25 (Auto: Biometrics; Descriptive: Biometrics – Gate), Prob: 1.00000000
Doc 185: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 1.00000000
Doc 186: Topic 15 (Auto: Statistical; Descriptive: Statistical), Prob: 1.00000000
Doc 187: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 0.74132884
Doc 188: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 0.77805120
Doc 189: Topic 24 (Auto: Estimation; Descriptive: Estimation), Prob: 0.82078850
Doc 190: Topic 41 (Auto: Vaccine; Descriptive: Vaccine – Immunological), Prob: 1.00000000
Doc 191: Topic 36 (Auto: Protec; Descriptive: Protec), Prob: 1.00000000
Doc 192: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 193: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 194: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 195: Topic 25 (Auto: Biometrics; Descriptive: Biometrics – Gate), Prob: 1.00000000
Doc 196: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 1.00000000
Doc 197: Topic 16 (Auto: Biometrics; Descriptive: Biometrics – Stratification), Prob: 0.52392556
Doc 198: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 0.83566485
Doc 199: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 200: Topic 16 (Auto: Biometrics; Descriptive: Biometrics – Stratification), Prob: 1.00000000
Doc 201: Topic 6 (Auto: Vaccine; Descriptive: Vaccine – Varicella), Prob: 1.00000000
Doc 202: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.43743931
Doc 203: Topic 16 (Auto: Biometrics; Descriptive: Biometrics – Stratification), Prob: 1.00000000
Doc 204: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 0.57754403
Doc 205: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 1.00000000
Doc 206: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.55601792
Doc 207: Topic 25 (Auto: Biometrics; Descriptive: Biometrics – Gate), Prob: 1.00000000
Doc 208: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 0.38069831
Doc 209: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 1.00000000
Doc 210: Topic 35 (Auto: 35; Descriptive: 35), Prob: 1.00000000
Doc 211: Topic 24 (Auto: Estimation; Descriptive: Estimation), Prob: 1.00000000
Doc 212: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 1.00000000
Doc 213: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 0.38647267
Doc 214: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 0.65101524
Doc 215: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 216: Topic 14 (Auto: Cohort; Descriptive: Cohort), Prob: 0.75735709
Doc 217: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 218: Topic 39 (Auto: Osdesign; Descriptive: Osdesign), Prob: 1.00000000
Doc 219: Topic 24 (Auto: Estimation; Descriptive: Estimation), Prob: 0.95861453
Doc 220: Topic 39 (Auto: Osdesign; Descriptive: Osdesign), Prob: 0.87483567
Doc 221: Topic 39 (Auto: Osdesign; Descriptive: Osdesign), Prob: 1.00000000
Doc 222: Topic 24 (Auto: Estimation; Descriptive: Estimation), Prob: 1.00000000
Doc 223: Topic 26 (Auto: Expertconsult; Descriptive: Expertconsult), Prob: 1.00000000
Doc 224: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 225: Topic 2 (Auto: Metrics; Descriptive: Metrics), Prob: 1.00000000
Doc 226: Topic 8 (Auto: Influenza; Descriptive: Influenza – Vaccines), Prob: 1.00000000
Doc 227: Topic 32 (Auto: Bioanalytical; Descriptive: Bioanalytical), Prob: 1.00000000
Doc 228: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.25481529
Doc 229: Topic 17 (Auto: Ebola; Descriptive: Ebola), Prob: 0.32993503
Doc 230: Topic 13 (Auto: Pneumococcal; Descriptive: Pneumococcal), Prob: 0.58323970
Doc 231: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.36598061
Doc 232: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 0.39385152
Doc 233: Topic 31 (Auto: Influenza; Descriptive: Influenza – Granzyme), Prob: 1.00000000
Doc 234: Topic 7 (Auto: Vaccine; Descriptive: Vaccine – Immune), Prob: 0.48108905
Doc 235: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.49641176
Doc 236: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 237: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.59574948
Doc 238: Topic 3 (Auto: Hiv; Descriptive: Hiv), Prob: 0.39445143
Doc 239: Topic 34 (Auto: Tuberculosis; Descriptive: Tuberculosis), Prob: 1.00000000
Doc 240: Topic 22 (Auto: Cd4; Descriptive: Cd4), Prob: 1.00000000
Doc 241: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 242: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 243: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 244: Topic 0 (Auto: Antibodies; Descriptive: Antibodies), Prob: 1.00000000
Doc 245: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 246: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 247: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 248: Topic 4 (Auto: Vaccines; Descriptive: Vaccines), Prob: 1.00000000
Doc 249: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 250: Topic 1 (Auto: Malaria; Descriptive: Malaria), Prob: 0.88905738
Doc 251: Topic 20 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 252: Topic 20 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.69956945
Doc 253: Topic 21 (Auto: Influenza; Descriptive: Influenza – Antibody – T21), Prob: 1.00000000
Doc 254: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 255: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 256: Topic 10 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
